Published on Mar 04, 2023
Jubilant Ingrevia IPO Price : Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Jubilant Ingrevia offers a broad portfolio of high quality ingredients that find application in wide range of industries. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.
Jubilant Ingrevia Ltd14
(JUBLINGREA | 543271 | INE0BY001018)
299.00 +14.20 (+4.99%)
JUBILANT INGREVIA LIMITED is categorized under Company limited by Shares and Public offering Manufacture of chemicals and chemical products as its principal business activity. Currently, it is in an Active status, owning a Corporate Identification Number U24299UP2019PLC122657 and a registration number 122657. The company is recorded under the registered address: Bhartiagram, Gajraula, DISTRICT AMROHA Jyotiba Phule Nagar UP 244223 IN.
The company is headed by ANANT PANDE, RAJESH KUMAR SRIVASTAVA, ARUN KUMAR SHARMA and DEEPANJALI GULATI and it was incorporated on Oct 23, 2019. It is classified as a Non-govt company, registered with the RoC-Kanpur.
JUBILANT INGREVIA LIMITED's Annual General Meeting (AGM) was lately held on Dec 1, 2020, and as per records from the Ministry of Corporate Affairs (MCA), its balance sheet was last filed on Mar 31, 2020, under the Registration of Companies at RoC-Kanpur. Its legalized share capital is 20,00,00,000 and its paid-up capital is 15,92,81,139.
Contact on the primary email address: deepanjali.gulati@jubl.com.
| NSE | |
|
282.1 13.40 (4.99%) |
|
| Day Open | 282.1 |
| Day High - Low | 282.1 - 282.1 |
| Previous Day Close | 268.7 |
| Total Traded Shares | 103188 |
| Total Number of Trades | 716 |
| Net Turnover (Rs) | 29109334.8 |
Jubilant Ingrevia Limited offers a broad portfolio of high quality ingredients that find application in wide range of industries. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.
They are driven by the motive to add value to millions of lives through innovations and cutting-edge technology. As a leader in key products we manufacture, we take pride in being a partner of choice for our valued customers.
Jubilant Ingrevia has a strong portfolio of bulk and fine Ingredients that are used as intermediates in more than 280 APIs of various therapeutic segments. We are a partner of choice to the top pharmaceutical customers.
Jubilant being fully backward integrated in most of these products provides cost effective, reliable and long term sustainable solutions to all its valuable customers.
• Pyridine
- Pyridine ACS / Pyridine 1 Degree
• Acetyl of Pyridine
• Cyanopyridines
• Amino Pyridines
• Picolines
• Carboxaldehyde of Pyridine
• Piperidine
• Carboxylate of Pyridine
• Carboxylic Acid of Pyridine
• Halo Pyridines
• Lutidines & Collidines
• Other Derivatives
• Picoline Derivatives
• Piperidine Derivatives
• Pyridine Salts
• Vitamin B3
• Life Science Chemicals Products
• Pyridine
